[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1) - Drugs in Development, 2021

 US$ 3,500.00

Prostaglandin G/H Synthase 2 (Cyclooxygenase 2 or COX2 or Prostaglandin Endoperoxide Synthase 2 or PHS II or Prostaglandin H2 Synthase 2 or PTGS2 or EC 1.14.99.1) - Drugs in Development, 2021 SUMMARY...

April 2021 230 pages

Prostaglandin G/H Synthase (Cyclooxygenase or COX or PTGS or EC 1.14.99.1) - Drugs in Development, 2021

 US$ 3,000.00

Prostaglandin G/H Synthase (Cyclooxygenase or COX or PTGS or EC 1.14.99.1) - Drugs in Development, 2021 SUMMARY Prostaglandin G/H Synthase (Cyclooxygenase or COX or PTGS or EC 1.14.99.1) - Drugs in De...

April 2021 45 pages

Protein Cysteine N Palmitoyltransferase Porcupine (Protein MG61 or PORCN or EC 2.3.1.) - Drugs in Development, 2021

 US$ 3,000.00

Protein Cysteine N Palmitoyltransferase Porcupine (Protein MG61 or PORCN or EC 2.3.1.) - Drugs in Development, 2021 SUMMARY Protein Cysteine N Palmitoyltransferase Porcupine (Protein MG61 or PORCN or...

April 2021 30 pages

Protein Disulfide Isomerase (Prolyl 4 Hydroxylase Subunit Beta or Cellular Thyroid Hormone Binding Protein or p55 or P4HB or EC 5.3.4.1) - Drugs in Development, 2021

 US$ 3,000.00

Protein Disulfide Isomerase (Prolyl 4 Hydroxylase Subunit Beta or Cellular Thyroid Hormone Binding Protein or p55 or P4HB or EC 5.3.4.1) - Drugs in Development, 2021 SUMMARY Protein Disulfide Isomeras...

April 2021 30 pages

Protein Kinase B (PKB or AKT or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Protein Kinase B (PKB or AKT or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Protein Kinase B (PKB or AKT or EC 2.7.11.1) - Drugs in Development, 2021 provides in depth analysis on Protein Kinase...

April 2021 60 pages

Protein Kinase C Delta Type (Tyrosine Protein Kinase PRKCD or nPKC Delta or PRKCD or EC 2.7.11.13 or EC 2.7.10.2) - Drugs in Development, 2021

 US$ 3,000.00

Protein Kinase C Delta Type (Tyrosine Protein Kinase PRKCD or nPKC Delta or PRKCD or EC 2.7.11.13 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Protein Kinase C Delta Type (Tyrosine Protein Kin...

April 2021 35 pages

Protein Kinase C (PKC or PRKC or EC 2.7.11.13) - Drugs in Development, 2021

 US$ 3,000.00

Protein Kinase C (PKC or PRKC or EC 2.7.11.13) - Drugs in Development, 2021 SUMMARY Protein Kinase C (PKC or PRKC or EC 2.7.11.13) - Drugs in Development, 2021 provides in depth analysis on Protein Ki...

April 2021 45 pages

Protein Tyrosine Phosphatase (EC 3.1.3.48) - Drugs in Development, 2021

 US$ 3,000.00

Protein Tyrosine Phosphatase (EC 3.1.3.48) - Drugs in Development, 2021 SUMMARY Protein Tyrosine Phosphatase (EC 3.1.3.48) - Drugs in Development, 2021 provides in depth analysis on Protein Tyrosine P...

April 2021 30 pages

Proteinase Activated Receptor 1 (PAR1 or Coagulation Factor II Receptor or Thrombin Receptor or F2R) - Drugs in Development, 2021

 US$ 3,000.00

Proteinase Activated Receptor 1 (PAR1 or Coagulation Factor II Receptor or Thrombin Receptor or F2R) - Drugs in Development, 2021 SUMMARY Proteinase Activated Receptor 1 (PAR1 or Coagulation Factor II...

April 2021 35 pages

Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) - Drugs in Development, 2021

 US$ 3,000.00

Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) - Drugs in Development, 2021 SUMMARY Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) - Drugs in Development, 2021 provides in depth an...

April 2021 50 pages

Proto Oncogene Mas (MAS1) - Drugs in Development, 2021

 US$ 3,000.00

Proto Oncogene Mas (MAS1) - Drugs in Development, 2021 SUMMARY Proto Oncogene Mas (MAS1) - Drugs in Development, 2021 provides in depth analysis on Proto Oncogene Mas (MAS1) targeted pipeline therapeu...

April 2021 35 pages

Protozoal Infection (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Protozoal Infection (Infectious Disease) - Drugs in Development, 2021 SUMMARY Protozoal Infection (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Protozoal Infection pipe...

April 2021 30 pages

Prurigo (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Prurigo (Dermatology) - Drugs in Development, 2021 SUMMARY Prurigo (Dermatology) - Drugs in Development, 2021 provides an overview of the Prurigo pipeline landscape. The report provides comprehensive...

April 2021 35 pages

Pseudomonas Aeruginosa Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,500.00

Pseudomonas Aeruginosa Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Pseudomonas Aeruginosa Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of...

April 2021 220 pages

Pseudomonas Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Pseudomonas Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Pseudomonas Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Pseudomonas Infect...

April 2021 35 pages

Psychiatric Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Psychiatric Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Psychiatric Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Psychiatric...

April 2021 125 pages

Psychosis (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Psychosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Psychosis (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Psychosis pipeline landscape. The re...

April 2021 70 pages

Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 SUMMARY Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Fibrosis pipeline landscape. T...

April 2021 95 pages

Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pulmonary Hypertension pip...

April 2021 65 pages

Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 SUMMARY Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Inflammation pipeline...

April 2021 50 pages

Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 2021

 US$ 2,000.00

Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 2021 SUMMARY Pulmonary Radiation Toxicity (Toxicology) - Drugs in Development, 2021 provides an overview of the Pulmonary Radiation To...

April 2021 35 pages

Pulmonary Tuberculosis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Pulmonary Tuberculosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Pulmonary Tuberculosis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Pulmonary Tubercul...

April 2021 50 pages

Q Fever (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Q Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Q Fever (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Q Fever pipeline landscape. The report provides...

April 2021 30 pages

Rab Proteins Geranylgeranyltransferase Component A 1 (Choroideremia Protein or Rab Escort Protein 1 or TCD Protein or CHM) - Drugs in Development, 2021

 US$ 3,000.00

Rab Proteins Geranylgeranyltransferase Component A 1 (Choroideremia Protein or Rab Escort Protein 1 or TCD Protein or CHM) - Drugs in Development, 2021 SUMMARY Rab Proteins Geranylgeranyltransferase C...

April 2021 30 pages

Radiation Injury (Toxicology) - Drugs in Development, 2021

 US$ 2,000.00

Radiation Injury (Toxicology) - Drugs in Development, 2021 SUMMARY Radiation Injury (Toxicology) - Drugs in Development, 2021 provides an overview of the Radiation Injury pipeline landscape. The repor...

April 2021 35 pages

Radiculopathy (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Radiculopathy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Radiculopathy (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Radiculopathy pipeline lands...

April 2021 30 pages

Ras (EC 3.6.5.2) - Drugs in Development, 2021

 US$ 3,000.00

Ras (EC 3.6.5.2) - Drugs in Development, 2021 SUMMARY Ras (EC 3.6.5.2) - Drugs in Development, 2021 provides in depth analysis on Ras (EC 3.6.5.2) targeted pipeline therapeutics. The report provides c...

April 2021 45 pages

Raynauds Disease (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Raynauds Disease (Cardiovascular) - Drugs in Development, 2021 SUMMARY Raynauds Disease (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Raynauds Disease pipeline landscape. T...

April 2021 30 pages

Receptor Activity Modifying Protein 1 (Calcitonin Receptor Like Receptor Activity Modifying Protein 1 or RAMP1) - Drugs in Development, 2021

 US$ 3,000.00

Receptor Activity Modifying Protein 1 (Calcitonin Receptor Like Receptor Activity Modifying Protein 1 or RAMP1) - Drugs in Development, 2021 SUMMARY Receptor Activity Modifying Protein 1 (Calcitonin R...

April 2021 35 pages

Receptor Activity Modifying Protein 3 (Calcitonin Receptor Like Receptor Activity Modifying Protein 3 or RAMP3) - Drugs in Development, 2021

 US$ 3,000.00

Receptor Activity Modifying Protein 3 (Calcitonin Receptor Like Receptor Activity Modifying Protein 3 or RAMP3) - Drugs in Development, 2021 SUMMARY Receptor Activity Modifying Protein 3 (Calcitonin R...

April 2021 35 pages

Receptor Interacting Serine/Threonine Protein Kinase 1 (Cell Death Protein RIP or Receptor Interacting Protein 1 or Serine/Threonine Protein Kinase RIP or RIP1 or RIPK1 or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

Receptor Interacting Serine/Threonine Protein Kinase 1 (Cell Death Protein RIP or Receptor Interacting Protein 1 or Serine/Threonine Protein Kinase RIP or RIP1 or RIPK1 or EC 2.7.11.1) - Drugs in Deve...

April 2021 45 pages

Receptor Tyrosine Kinase (RTK) - Drugs in Development, 2021

 US$ 3,000.00

Receptor Tyrosine Kinase (RTK) - Drugs in Development, 2021 SUMMARY Receptor Tyrosine Kinase (RTK) - Drugs in Development, 2021 provides in depth analysis on Receptor Tyrosine Kinase (RTK) targeted pi...

April 2021 30 pages

Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 SUMMARY Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 provides an overview of the Recu...

April 2021 210 pages

Recurrent Head And Neck Cancer Squamous Cell Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Recurrent Head And Neck Cancer Squamous Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Recurrent Head And Neck Cancer Squamous Cell Carcinoma (Oncology) - Drugs in Development, 2021 pr...

April 2021 170 pages

Recurrent Medulloblastoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Recurrent Medulloblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Recurrent Medulloblastoma (Oncology) - Drugs in Development, 2021 provides an overview of the Recurrent Medulloblastoma pipeli...

April 2021 40 pages

Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Acute...

April 2021 425 pages

Refractory Angina (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Refractory Angina (Cardiovascular) - Drugs in Development, 2021 SUMMARY Refractory Angina (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Refractory Angina pipeline landscape...

April 2021 30 pages

Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 SUMMARY Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview...

April 2021 170 pages

Refractory Medulloblastoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Refractory Medulloblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Refractory Medulloblastoma (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Medulloblastoma pip...

April 2021 30 pages

Refractory Multiple Myeloma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Refractory Multiple Myeloma (Oncology) - Drugs in Development, 2021 SUMMARY Refractory Multiple Myeloma (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Multiple Myeloma...

April 2021 425 pages

Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Acute Myelo...

April 2021 425 pages

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 SUMMARY Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview of...

April 2021 170 pages

Relapsed Multiple Myeloma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Relapsed Multiple Myeloma (Oncology) - Drugs in Development, 2021 SUMMARY Relapsed Multiple Myeloma (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Multiple Myeloma pipeli...

April 2021 425 pages

Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021 provides an ov...

April 2021 45 pages

Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Developmen...

April 2021 95 pages

Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,500.00

Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Renal Cell Carcinoma pipeline landscape. T...

April 2021 375 pages

Renal Failure (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

 US$ 2,000.00

Renal Failure (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Renal Failure (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 provides an overview of...

April 2021 40 pages

Resistant Hypertension (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Resistant Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Resistant Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Resistant Hypertension pip...

April 2021 40 pages

Respiratory Depression (Hypoventilation) (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Respiratory Depression (Hypoventilation) (Respiratory) - Drugs in Development, 2021 SUMMARY Respiratory Depression (Hypoventilation) (Respiratory) - Drugs in Development, 2021 provides an overview of...

April 2021 30 pages

Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Drugs in Development, 2021

 US$ 3,000.00

Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Drugs in Development, 2021 SUMMARY Respiratory Syncytial Virus Fusion Protein (RSV F Protein) - Drugs in Development, 2021 provides in dept...

April 2021 95 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1